用AAV9-介导的基因疗法治疗婴儿发病的庞培病
Xiuwei Ma1,2,3,4, Lu Zhuang1,2,3,4, Wenhao Ma5
1Department of Pediatrics, Chinese People's Liberation Army (PLA) General Hospital, Beijing.
The New England journal of medicine
|June 25, 2025
概括
基因疗法对婴儿佩病有前途. 在大多数患者中,AAV-GAA治疗改善了心脏和运动功能,没有检测到抗GAA抗体. 呼吸道感染是主要的副作用.
科学领域:
- 医学遗传学 医学遗传学
- 神经学 神经学
- 生物技术是生物技术.
背景情况:
- 婴儿发病的庞培病是一种罕见的遗传性疾病,导致肌肉逐渐衰弱.
- 目前的治疗方法有限,这凸显了对新型治疗策略的需求.
- 酶替代疗法已经显示出一些疗效,但面临挑战.
研究的目的:
- 评估腺相关病毒血清型9 (AAV9) 基因疗法的安全性和有效性,用于婴儿发病的庞培病.
- 评估AAV-GAA治疗后心脏和运动功能的改善.
- 监测基因治疗载体的不良事件和免疫反应.
主要方法:
- 四名患有婴儿庞培病的患者接受了编码人类酸α-葡萄糖酶 (GAA) 的AAV9载体的单次静脉输注.
- 给出的剂量为每公斤1.2 × 10^14个载体基因组.
- 患者被监测了52周的临床结果,心脏功能,运动发育和免疫反应.
主要成果:
- 在52周内,四分之三的患者表现出心脏结果和运动功能的改善.
- 在观察期间,在任何患者身上都没有检测到抗GAA抗体.
- 呼吸道感染是最频繁报告的不良事件; 一名患者被撤离并死亡.
结论:
- 以AAV9为媒介的基因疗法是婴儿发病的庞培病的潜在治疗方法,证明了临床益处.
- 在免疫性方面,治疗似乎是安全的,没有观察到抗GAA抗体.
- 需要进一步的研究和更大的试验来确认疗效和长期安全性.
相关概念视频
00:59Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K